First Reversals of Cognitive Decline in Alzheimer’s Disease is a November Commonwealth Club release. The speaker, Dr Bredesen of the Bucks Institute, reports on an integrative, holistic approach to AD.
The most evident symptoms of AD were identified as being poor memory, being easily overwhelmed and getting lost. Dr Dale Bredesen presented information, slides, and short videos on Alzheimer’s disease predicting the number of sufferers in the years to come, the impact on society, and some examples of his patients who had reclaimed their memories. He showed that the current mono-therapy treatment is failing because AD is a metabolic disorder involving 36 metabolic imbalances that the current therapy does not address.
Then Dr. Bresdesen describes his comprehensive, personalized therapeutic program designed to achieve metabolic enhancement for neurodegeneration (MEND) based on the underlying pathogenesis of Alzheimer’s disease involving multiple modalities. The first 10 patients who have utilized this program include patients with memory loss associated with Alzheimer’s disease (AD), amnestic mild cognitive impairment (aMCI), or subjective cognitive impairment (SCI). Nine of the 10 displayed subjective or objective improvement in cognition beginning within 3-6 months, with the one failure being a patient with very late stage AD. Six of the patients had had to discontinue working or were struggling with their jobs at the time of presentation, and all were able to return to work or continue working with improved performance. Improvements have been sustained, and at this time the longest patient follow-up is two and one-half years from initial treatment, with sustained and marked improvement.
His results suggest early in the course of the disease cognitive decline addressing metabolic processes and using a therapeutic system may be the key to success. Great to know that there is hope if we address the symptoms opening as so as they begin to occur.